Moderna
MRNA
#1323
Rank
โ‚ฌ12.42 B
Marketcap
32,13ย โ‚ฌ
Share price
3.70%
Change (1 day)
-68.20%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚ฌ2.97 Billion

According to Moderna 's latest financial reports the company's total liabilities are โ‚ฌ2.97 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ3.11 B-24.69%
2023-12-31โ‚ฌ4.13 B-34.13%
2022-12-31โ‚ฌ6.27 B-32.43%
2021-12-31โ‚ฌ9.29 B139.32%
2020-12-31โ‚ฌ3.88 B949.13%
2019-12-31โ‚ฌ0.37 B-1.97%
2018-12-31โ‚ฌ0.37 B-1.35%
2017-12-31โ‚ฌ0.38 B-30.03%
2016-12-31โ‚ฌ0.54 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ6.38 M-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ64.91 B 2,082.47%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ40.22 M-98.65%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.82 B 28.75%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ53.34 B 1,693.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ0.87 B-70.45%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ99.68 B 3,251.25%๐Ÿ‡บ๐Ÿ‡ธ USA